FDA Special Assistant Høeg’s Vaccine Concerns On Display At ACIP

Tracy Beth Høeg, who is reportedly re-examining Novavax’s COVID vaccine application, is the FDA rep at the CDC panel’s first meeting under the Trump Administration. She raised concerns about routine use of Jynneos for adolescents at risk of mpox and questioned how Moderna assessed efficacy of its COVID vaccines.

Mpox vaccine
A top FDA official questioned the safety of routine vaccination of adolescents at risk for mpox. (Shutterstock)

More from Vaccines

More from Agency Leadership